Researchers Develop Novel Drug Delivery System
Links shared publicly online about this topic.
- 0total visits
Researchers Develop Novel Drug Delivery System
View full resource at medicalnewstoday.com
Tags: Pain, Chronic Pain, Drug, Medical
Most Recently Shared on February 3, 2012 at 3:57 am By:
Researchers Develop Novel Drug Delivery System: Long duration, controllable drug delivery is of wide interest to... http://t.co/XzHCnKxQ
Also Shared By:
Hopkins Launches New ALS Research Center with $25 Million Gift - 03/21/2012
hopkinsmedicine.org — “A $25 million gift has enabled Johns Hopkins to establish a new center to develop novel therapies for the neurodegenerative disease known as amyotrophic lateral sclerosis, Lou Gehrig’s disease, or ALS. Much of the center’s research will focus on using stem cells individually derived from ALS patients to develop new model systems to investigate how nerve cells degenerate, as tools to screen new drug therapies, and to develop stem cell therapies as transplants to potentially slow or reverse the di” View full resource at hopkinsmedicine.org
Most Recently Shared on March 23, 2012 at 2:32 pm By:
JohnsHopkinsMedicine Health News
A $25 million gift has enabled Johns Hopkins to establish a new #ALS center. http://t.co/xeL7Nkl1
NanoSmart(TM) Pharmaceuticals Joins Forces with Children's Hospital Los Angeles to Fight Pediatric Cancer - PR Newswire - sacbee.com
sacbee.com — “/PRNewswire/ -- NanoSmart Pharmaceuticals, Inc., a corporation developing novel cancer pharmaceuticals, has entered into a research collaboration with Children's Hospital Los Angeles, one of the nation's top pediatric hospitals, to develop and assess NanoSmart's novel drug-delivery platform.” View full resource at sacbee.com
Most Recently Shared on November 2, 2011 at 1:22 pm By:
Bruce Shriver Patient Advocate, PhD, Doctor, and Health Advocate
NanoSmart(TM) Pharmaceuticals Joins Forces with Children's Hospital Los Angeles to Fight Sarcoma - http://t.co/rjWco4Hp
Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban
news-medical.net — “Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.” View full resource at news-medical.net
Most Recently Shared on September 9, 2011 at 8:24 am By:
News-Medical.Net Health News and Oncology
Oncology News: Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban... http://t.co/X1iH6Uy
Aura's NanoSmart platform can enable earlier detection, treatment of cancers
news-medical.net — “Aura Biosciences, Inc., a biotech company focused on the development of nano-enabled drug delivery systems, has completed several pre-clinical research programs. The resulting data suggest that Aura's NanoSmart platform can enable earlier detection of cancers and distant metastases; and then provide precisely targeted treatment of those cancers.” View full resource at news-medical.net
Most Recently Shared on September 9, 2011 at 5:06 am By:
Aura's NanoSmart platform can enable earlier detection, treatment of cancers: Aura Biosciences, Inc., a biotech ... http://t.co/fNdoC3R
Nanoparticles Disguised as Red Blood Cells To Fight Cancer
newswise.com — “Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body’s immune system and deliver cancer-fighting drugs straight to a tumor.” View full resource at newswise.com
Most Recently Shared on June 21, 2011 at 2:00 pm By:
#health news: Nanoparticles Disguised as Red Blood Cells To Fight Cancer: Researchers at the University of Calif... http://bit.ly/mMgxUK
Nanoparticles Disguised as Red Blood Cells To Fight Cancer
newswise.com — “Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body’s immune system and deliver cancer-fighting drugs straight to a tumor.” View full resource at newswise.com
Most Recently Shared on June 21, 2011 at 1:18 pm By:
Nanoparticles Disguised as Red Blood Cells To Fight Cancer: Researchers at the University of California,... http://bit.ly/kFVRbk #cancer
Nanoparticles disguised as red blood cells will deliver cancer-fighting drugs
eurekalert.org — “Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body's immune system and deliver cancer-fighting drugs straight to a tumor. Their research will be published next week in the online early edition of the Proceedings of the National Academies of Science.” View full resource at eurekalert.org
Most Recently Shared on June 20, 2011 at 8:36 pm By:
Drugs and Devices OW OW Health
Nanoparticles disguised as red blood cells will deliver cancer-fighting drugs: ( University of California - San ... http://bit.ly/lANgru
Nanoparticles disguised as red blood cells deliver cancer-fighting drugs
physorg.com — “Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body's immune system and deliver cancer-fighting drugs straight to a tumor. Their research will be published next week in the online ...” View full resource at physorg.com
Most Recently Shared on June 20, 2011 at 7:58 pm By:
Nanoparticles disguised as red blood cells deliver cancer-fighting drugs http://bit.ly/mncbTv
CEVEC and Catalent Pharma Solutions offer joint cell line development service
news-medical.net — “CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC’s human cell line, CAP-Technology, with Catalent’s unique GPEx® (Gene Product Expression) Technology to generate hig” View full resource at news-medical.net
Most Recently Shared on June 16, 2011 at 11:58 pm By:
Genetics News: CEVEC and Catalent Pharma Solutions offer joint cell line development service: CEVEC Pharmaceutic... http://bit.ly/lkQPYb
3M, Radius collaborate to develop BA058 for treatment of osteoporosis
news-medical.net — “Radius Health, Inc. and 3M Drug Delivery Systems today announced an agreement to collaborate on the development of a transdermal delivery option of BA058, Radius' novel, proprietary PTHrP analog, for the treatment of osteoporosis.” View full resource at news-medical.net
Most Recently Shared on May 24, 2011 at 3:28 pm By:
Osteoporosis News: 3M, Radius collaborate to develop BA058 for treatment of osteoporosis: Radius Health, Inc. an... http://bit.ly/lmQ2ZX
Online Medical Chats | NorthShore University HealthSystem
northshore.org — “NorthShore is an integrated healthcare delivery system including Evanston, Glenbrook, Highland Park and Skokie Hospitals, a Medical Group, Research Institute, Home Health Services and Foundation. We are located in the northern Chicago suburbs.” View full resource at northshore.org
Most Recently Shared on May 18, 2011 at 6:10 pm By:
Q15 - "Are there any other complications that can develop from a stroke - such as a heart attack or cancer?" http://bit.ly/maeq6h #nschat
ETP makes investment to support development of ICVrx's targeted epilepsy drug technology
news-medical.net — “Epilepsy Therapy Project, a non-profit organization whose mission is to accelerate new therapies for people living with epilepsy and seizures, and ICVrx, LLC, a pharmacy product research and development company focused on novel therapies for central nervous system disorders, announced today that ETP has made an investment in ICVrx to support the development of ICVrx's targeted epilepsy drug technology for patients whose seizures are not controlled by current therapies.” View full resource at news-medical.net
Most Recently Shared on April 30, 2011 at 5:39 am By:
ETP makes investment to support development of ICVrx's targeted epilepsy drug technology: Epilepsy Therapy Proje... http://bit.ly/j6rnnC
Novel immune therapy for pancreatic cancer - News - Virtual Medical Centre
virtualmedicalcentre.com — “Researchers have discovered a novel way of treating pancreatic cancer by activating the immune system to destroy the cancer's scaffolding. The findings could lead to quicker, less expensive cancer drug development.” View full resource at virtualmedicalcentre.com
Most Recently Shared on April 16, 2011 at 2:04 pm By:
VirtualMedicalCentre Health Site
Novel immune therapy for pancreatic cancer http://dlvr.it/Nj8GP #Healthnews
Yissum Presents Promising Pre-Clinical Results For Oral Delivery Of The Anti-Cancer Drug Docetaxel Using A Novel Nanotechnology Approach
medicalnewstoday.com — “Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today successful pre-clinical data of oral delivery of Docetaxel, an anti” View full resource at medicalnewstoday.com
Most Recently Shared on April 12, 2011 at 11:05 am By:
MNT Pharma News Pharma and Health News
Yissum Presents Promising Pre-Clinical Results For Oral Delivery Of The Anti-Cancer Drug Docetaxel Using A Novel Nanot... http://mnt.to/3Twy
Advertisement
MNT Medical Devices
@mnt_medicaldev
Researchers Develop Novel Drug Delivery System http://t.co/dZSszPZ8 #medicaldevices
1 year ago...